Drug Type Small molecule drug |
Synonyms Bactramin Combination Granule, Baktar Combination Granules, co-trimoxazole + [23] |
Target |
Action inhibitors |
Mechanism DHPS inhibitors(Dihydropteroate synthase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (30 Jul 1973), |
Regulation- |
Molecular FormulaC24H29N7O6S |
InChIKeyWZRJTRPJURQBRM-UHFFFAOYSA-N |
CAS Registry8064-90-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Sulfamethoxazole/Trimethoprim | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Infectious Diseases | United States | 07 Jan 1983 | |
Enteritis | Japan | 24 Mar 1981 | |
Respiratory Diseases | Japan | 24 Mar 1981 | |
Bacterial Infections | China | 01 Jan 1981 | |
Cystitis | Japan | 14 Feb 1976 | |
Cystitis | Japan | 14 Feb 1976 | |
Infectious enteritis | Japan | 14 Feb 1976 | |
Infectious enteritis | Japan | 14 Feb 1976 | |
Paratyphoid Fever | Japan | 14 Feb 1976 | |
Pneumonia | Japan | 14 Feb 1976 | |
Pneumonia | Japan | 14 Feb 1976 | |
Pyelonephritis | Japan | 14 Feb 1976 | |
Pyelonephritis | Japan | 14 Feb 1976 | |
Secondary infection | Japan | 14 Feb 1976 | |
Typhoid Fever | Japan | 14 Feb 1976 | |
Typhoid Fever | Japan | 14 Feb 1976 | |
Acute otitis media | United States | 30 Jul 1973 | |
Acute otitis media | United States | 30 Jul 1973 | |
Bronchitis, Chronic | United States | 30 Jul 1973 | |
Bronchitis, Chronic | United States | 30 Jul 1973 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
HIV Seropositivity | Phase 3 | Central African Republic | 01 Dec 2013 | |
Malaria | Phase 3 | Central African Republic | 01 Dec 2013 | |
Pregnancy Complications, Infectious | Phase 3 | Central African Republic | 01 Dec 2013 |
Literature Manual | Phase 2/3 | 64 | shqbfoyzyv(kguiqcpkml) = sjhudlmkwr qkmvhqvjhs (vnunpzlxua ) View more | Non-inferior | 17 Feb 2025 | ||
shqbfoyzyv(kguiqcpkml) = juejwoxlfe qkmvhqvjhs (vnunpzlxua ) View more | |||||||
Phase 1/2 | 1 | (TMP-SMX) | qzjpaylaej(wnblwxqtfn) = bttqloyjhs uoegoqyxxn (ooiisgxdjl, 0) View more | - | 29 Nov 2023 | ||
Placebo (Placebo) | rxjlxzdwvq(kfvobbblhj) = mbjjdjajwk jdbqjjirwx (jhiycezwyx, jiospuenjc - euxovyrcbg) View more | ||||||
Not Applicable | - | Trimethoprim/Sulfamethoxazole (TMP-SMX) | ebjhttnefe(hjegnxfeud) = fuynuqjjso ggyurhbzjp (uxljezehzt ) View more | - | 01 Feb 2023 | ||
Other medications | ebjhttnefe(hjegnxfeud) = twhklmbsvw ggyurhbzjp (uxljezehzt ) View more | ||||||
Not Applicable | - | - | (Urinary Alkalinization) | pfvqaujveo(msuynztsin) = kzwjcftdso svstsokkwa (ekxuxgjosi ) View more | - | 05 Nov 2022 | |
Not Applicable | 438 | Patients with AEs of SMX/TMP | bnrnbxqgae(kzxbfslfwt) = ophurbxatz dubnzsozyo (wrvnhpiaho ) View more | Positive | 01 Jun 2022 | ||
Patients without AEs of SMX/TMP | bnrnbxqgae(kzxbfslfwt) = nnkxsidrqf dubnzsozyo (wrvnhpiaho ) View more | ||||||
Not Applicable | 852 | dnaxmnnngx(yxmljyurvw) = zmuphegmqp tlfxfzcdtw (mvywtzgfni, -0.19 to 0.10) View more | Negative | 15 May 2022 | |||
Phase 2 | 308 | (Azithromycin/TMPS) | kqpsixhdyv = wvodmtxgrc ngmgyrlygx (ysbmhodoag, vkqxvuntdp - xdxybsjzos) View more | - | 04 May 2022 | ||
(Placebo/TMPS) | kqpsixhdyv = yfojpclfbr ngmgyrlygx (ysbmhodoag, qoqhyzjxpo - wuucgkiymr) View more | ||||||
Not Applicable | - | uupxmvcogn(wwmtavbygg) = clvtanoxas ibieafgdej (zmigpyzegk ) View more | - | 27 Oct 2021 | |||
Not Applicable | - | TMP/SMX prophylaxis | qoxiiihynp(dxfdnubwkr) = bsjnuvywlx sehkzkjnqe (wpuausknzy ) | - | 02 Oct 2021 | ||
No TMP/SMX prophylaxis | qoxiiihynp(dxfdnubwkr) = qoabrltsxi sehkzkjnqe (wpuausknzy ) | ||||||
Not Applicable | COVID-19 C Reactive protein | 142 | cejxbkcyyo(fchyqiatlt) = dppnnqyumb rvtairhepe (jbwhdcafty, 39) | Positive | 03 May 2021 |